Report Detail

Pharma & Healthcare Global Romiplostim Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3646061
  • |
  • 06 August, 2019
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.

Scope of the Report:
The global Romiplostim market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Romiplostim.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Romiplostim market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Romiplostim market by product type and applications/end industries.

Market Segment by Companies, this report covers
AMGEN

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
250 μg/0.5 mL
500 μg/1 mL

Market Segment by Applications, can be divided into
Adults
Pediatric patients


Table of Contents

    1 Romiplostim Market Overview

    • 1.1 Product Overview and Scope of Romiplostim
    • 1.2 Classification of Romiplostim by Types
      • 1.2.1 Global Romiplostim Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Romiplostim Revenue Market Share by Types in 2018
      • 1.2.3 250 μg/0.5 mL
      • 1.2.4 500 μg/1 mL
    • 1.3 Global Romiplostim Market by Application
      • 1.3.1 Global Romiplostim Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Adults
      • 1.3.3 Pediatric patients
    • 1.4 Global Romiplostim Market by Regions
      • 1.4.1 Global Romiplostim Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Romiplostim Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Romiplostim Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Romiplostim Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Romiplostim Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Romiplostim Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Romiplostim (2014-2024)

    2 Manufacturers Profiles

    • 2.1 AMGEN
      • 2.1.1 Business Overview
      • 2.1.2 Romiplostim Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Romiplostim Market Competition, by Players

    • 3.1 Global Romiplostim Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Romiplostim Players Market Share
      • 3.2.2 Top 10 Romiplostim Players Market Share
    • 3.3 Market Competition Trend

    4 Global Romiplostim Market Size by Regions

    • 4.1 Global Romiplostim Revenue and Market Share by Regions
    • 4.2 North America Romiplostim Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Romiplostim Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Romiplostim Revenue and Growth Rate (2014-2019)
    • 4.5 South America Romiplostim Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Romiplostim Revenue and Growth Rate (2014-2019)

    5 North America Romiplostim Revenue by Countries

    • 5.1 North America Romiplostim Revenue by Countries (2014-2019)
    • 5.2 USA Romiplostim Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Romiplostim Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Romiplostim Revenue and Growth Rate (2014-2019)

    6 Europe Romiplostim Revenue by Countries

    • 6.1 Europe Romiplostim Revenue by Countries (2014-2019)
    • 6.2 Germany Romiplostim Revenue and Growth Rate (2014-2019)
    • 6.3 UK Romiplostim Revenue and Growth Rate (2014-2019)
    • 6.4 France Romiplostim Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Romiplostim Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Romiplostim Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Romiplostim Revenue by Countries

    • 7.1 Asia-Pacific Romiplostim Revenue by Countries (2014-2019)
    • 7.2 China Romiplostim Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Romiplostim Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Romiplostim Revenue and Growth Rate (2014-2019)
    • 7.5 India Romiplostim Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Romiplostim Revenue and Growth Rate (2014-2019)

    8 South America Romiplostim Revenue by Countries

    • 8.1 South America Romiplostim Revenue by Countries (2014-2019)
    • 8.2 Brazil Romiplostim Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Romiplostim Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Romiplostim Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Romiplostim by Countries

    • 9.1 Middle East and Africa Romiplostim Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Romiplostim Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Romiplostim Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Romiplostim Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Romiplostim Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Romiplostim Revenue and Growth Rate (2014-2019)

    10 Global Romiplostim Market Segment by Type

    • 10.1 Global Romiplostim Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Romiplostim Market Forecast by Type (2019-2024)
    • 10.3 250 μg/0.5 mL Revenue Growth Rate (2014-2024)
    • 10.4 500 μg/1 mL Revenue Growth Rate (2014-2024)

    11 Global Romiplostim Market Segment by Application

    • 11.1 Global Romiplostim Revenue Market Share by Application (2014-2019)
    • 11.2 Romiplostim Market Forecast by Application (2019-2024)
    • 11.3 Adults Revenue Growth (2014-2019)
    • 11.4 Pediatric patients Revenue Growth (2014-2019)

    12 Global Romiplostim Market Size Forecast (2019-2024)

    • 12.1 Global Romiplostim Market Size Forecast (2019-2024)
    • 12.2 Global Romiplostim Market Forecast by Regions (2019-2024)
    • 12.3 North America Romiplostim Revenue Market Forecast (2019-2024)
    • 12.4 Europe Romiplostim Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Romiplostim Revenue Market Forecast (2019-2024)
    • 12.6 South America Romiplostim Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Romiplostim Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Romiplostim. Industry analysis & Market Report on Romiplostim is a syndicated market report, published as Global Romiplostim Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Romiplostim market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,239.88
      4,859.82
      6,479.76
      531,361.20
      797,041.80
      1,062,722.40
      293,712.00
      440,568.00
      587,424.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report